Top Markets
#1 Siren Siren +38.80%
#2 RedStone RedStone +24.34%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.68%
#4 Ocean Protocol Ocean Protocol +15.45%
#5 KUB Coin KUB Coin +14.83%
#6 Perle Perle +12.11%
#7 Nosana Nosana +10.27%
#8 Wiki Cat Wiki Cat +9.55%
#9 Nockchain Nockchain +8.82%
#10 Arowana Arowana +8.55%
Coin of the day
Siren Siren
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Antibe Therapeutics Inc. Antibe Therapeutics Inc.

Antibe Therapeutics Inc.

ATE
Peringkat dalam Saham #32097
Antibe Therapeutics Inc. is a biotechnology company specializing in the... Antibe Therapeutics Inc. is a biotechnology company specializing in the development of groundbreaking therapeutics and medical devices. Operating internationally, including Canada, Europe, and the United States, their work targets pain, inflammation, and regenerative medicine. A key focus is developing drugs designed to prevent the gastrointestinal harm and bleeding often caused by non-steroidal anti-inflammatory drugs. Their leading candidate, Otenaproxesul, is a hydrogen sulfide-releasing derivative of naproxen. This compound has already finished a Phase 2B gastrointestinal safety study and is being investigated for a range of indications, such as post-operative pain, migraines, dysmenorrhea, traumatic injuries, dental pain, and gout. Additionally, their product portfolio features ATB-352, currently in preclinical development for managing acute pain. The company, incorporated in 2009, is headquartered in Toronto, Canada.
Harga Saham
$0.21483059
Terakhir disinkronkan: 2024-05-07
Kapitalisasi Pasar
$11.13M
Perubahan (1 hari)
0.34%
Perubahan (1 tahun)
0.00%
Negara
CA
Perdagangan Antibe Therapeutics Inc. (ATE)

Kategori

Healthcare
Pendapatan untuk Antibe Therapeutics Inc. (ATE)
Pendapatan pada Aug 2026 TTM: 0
Menurut laporan keuangan terbaru dari Antibe Therapeutics Inc., pendapatan saat ini (TTM) adalah 0. Pada tahun 2026, perusahaan menghasilkan pendapatan sebesar 0 sama dengan pendapatan pada tahun 2026 yang sebesar 0. Pendapatan adalah jumlah total yang dihasilkan dari penjualan barang atau jasa. Tidak seperti laba, tidak ada pengeluaran yang dikurangkan.
Riwayat pendapatan Antibe Therapeutics Inc. dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Pendapatan untuk perusahaan serupa atau pesaing
Perusahaan Pendapatan Perbedaan Pendapatan Negara
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B -
US